Immunotherapy of B cell lymphoma with CD22-redirected CAR NK-92 cells

Introduction: Chimeric antigen receptor (CAR)-NK cells are considered safer than CAR-T cells due to their short lifetime and production of lower toxicity cytokines. By virtue of unlimited proliferative ability in vitro, NK-92 cells could be utilized as the source for CAR-engineered NK cells. CD22 is...

Descripción completa

Detalles Bibliográficos
Autores principales: Tian, Xiaopeng, Zhang, Ruixi, Qin, Huimin, Shi, Xiangru, Qi, Wenhui, Jiang, Dongpeng, Zhu, Tingting, Sun, Aining
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Termedia Publishing House 2023
Materias:
Experimental Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10189576/
https://www.ncbi.nlm.nih.gov/pubmed/37206593
http://dx.doi.org/10.5114/ceji.2023.126672

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10189576/
https://www.ncbi.nlm.nih.gov/pubmed/37206593
http://dx.doi.org/10.5114/ceji.2023.126672

Ejemplares similares